Foot And Mouth Disease Vaccine Market to grow at highest pace owing to rising cattle population

The foot and mouth disease (FMD) vaccine market comprises vaccines that aid in preventing and controlling the spread of foot-and-mouth disease (FMD) in livestock animals including cattle, pigs, sheep, and goats. FMD is a highly contagious viral disease that impacts cloven-hoofed animals. It causes fever, blisters inside the mouth and on feet that cause lameness. The FMD vaccines available in the market include unit dose vaccine, bivalent vaccine, and emergency vaccine. The vaccines provide adequate immunization levels and help protect animals from getting infected. With the increasing cattle population worldwide due to the growing demand for dairy and meat products, the risk of FMD outbreak has augmented substantially, necessitating preventive vaccination of livestock on a large scale.

The Global Foot And Mouth Disease Vaccine Market is estimated to be valued at US$ 5.6 Bn in 2024 and is expected to exhibit a CAGR of 11.% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the foot and mouth disease (FMD) vaccine are Banner Engineering Corporation, Rockwell Automation Inc., Pepperl+Fuchs SE, Emerson Electric Company, Panasonic Industry Europe GmbH (Panasonic Corporation), Honeywell International Inc., Sick AG, Yokogawa Electric Corporation, Omron Corporation, ABB Ltd., General Electric Company, Schneider Electric SE, and Siemens AG.

The growing Foot And Mouth Disease Vaccines Market Demand for dairy and meat from the increasing population worldwide has augmented the cattle population. Rising cattle population directly increases the risk of FMD outbreak, necessitating large-scale vaccination of livestock. Advancements in vaccine production technologies have allowed developing more effective vaccines that provide improved immunization against the FMD virus and its various strains.

Market Trends

The major trends in the foot and mouth disease (FMD) vaccine market include the development of thermostable and cold chain free vaccines. Conventional FMD vaccines require stringent cold chain maintenance during storage and transportation to farms which increases logistical challenges and costs. The development of thermostable vaccines that do not require refrigeration removes these challenges and facilitates widespread livestock vaccination. Another key trend is the development of polyvalent and matched vaccines. While conventional FMD vaccines only provide protection against one serotype, polyvalent vaccines offer protection against multiple serotypes prevalent in a particular region. This significantly improves immunization levels.

Market Opportunities

The development of advanced vaccines that can differentiate infected livestock from vaccinated animals (DIVA vaccines) presents a major market opportunity. At present, it is difficult to distinguish animals vaccinated with regular FMD vaccines from those that got naturally infected. DIVA vaccines allow such differentiation through antibody detection tests. This aids effective disease control and international trade. Secondly, regions with developing livestock industry and increasing FMD outbreaks such as Asia Pacific and Latin America expect significant vaccination drives. Local production of FMD vaccines in such regions through technology transfers presents lucrative business opportunities.

Impact of COVID-19 on Foot and Mouth Disease Vaccine Market Growth
The outbreak of COVID-19 pandemic has adversely impacted the growth of the global foot and mouth disease vaccine market in the initial months of 2020. The lockdowns imposed by various governments globally disrupted the supply chain and logistics, hampering the production and distribution of FMD vaccines across markets. Various plants manufacturing FMD vaccines had to temporarily shut down operations due to travel restrictions and shortage of workforce. This led to decline in sales and restricted the accessibility of vaccines to the farmers, posing challenges to control and eradicate the disease.

However, with vaccination being one of the preventive measures adopted to protect livestock from contracting viruses, the demand is anticipated to surge in the post-COVID era. The market players are focusing on ramping up their production capabilities through strategic collaborations to ensure sustained supply and cater to the increasing requirements. The governments are also supporting the manufacturers by providing incentives and subsidies to develop more effective and affordable vaccines.

Europe Dominates the Foot and Mouth Disease Vaccine Market in Terms of Value
The Europe region holds the leading share in the global foot and mouth disease vaccine market and accounts for over 30% of the total market value. The high prevalence of FMD in countries like United Kingdom, Germany, Italy and Spain along with growing awareness about vaccine benefits among farmers have been the major factor driving the Europe market. Stringent regulations regarding livestock health in the European Union further encourage widespread vaccination practices. Apart from Europe, South Asia is another core geographical region concentrated for FMD vaccines. Countries like India, Pakistan, Bangladesh and Sri Lanka grapple with recurrent outbreaks owing to large cattle population and need for constant immunization drives.

South East Asia Emerges as the Fastest Foot And Mouth Disease Vaccine Companies Region in the Foot and Mouth Disease Vaccine Market
While North America, Latin America and Europe dominate the current footprint of global FMD vaccine market, South East Asia region is identified to exhibit fastest market growth during the forecast period. Rising meat consumption in Indonesia, Vietnam, Thailand and Malaysia along with increasing middle class population has amplified the demand for protein sources like meat and milk in the Southeast Asian countries. This has encouraged greater focus on livestock protection and disease control measures including vaccines. Growing bilateral and multilateral collaborations between countries in the region also support knowledge and technology transfer for effective immunization programs. Developing rural infrastructure and favourable government funding towards animal healthcare further support faster market expansion of FMD vaccines in Southeast Asia.

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )